Recently it has been reported [22] that Epigallocatechin Gallate (EGCG) enhances the sensitivity of colorectal cancer cells to 5FU by Inhibiting GRP78/NF-κB/miR-155- 5p/MDR1 pathway. Here, HSPA5 is linked to colorectal cancer.